ImmunityBio, Inc.
(IBRX - NASDAQ)
7,24 USD
📋 Profilo Aziendale

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases.

|